Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.

about

CT-P13 in the treatment of rheumatoid arthritis.Comparative effectiveness of the biosimilar CT-P13.

P2860

Q38676104-79723AE5-AE94-42C2-962F-15EA006C244A Q47418286-3F84BA42-3762-4EB9-8639-A91A323D042C

P2860

Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.

Item

http://www.wikidata.org/entity/Q38953729

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Characteristics and outcomes o ...... started biosimilar infliximab.

@en

type

Item

label

Characteristics and outcomes o ...... started biosimilar infliximab.

@en

prefLabel

Characteristics and outcomes o ...... started biosimilar infliximab.

@en

P1476

Characteristics and outcomes o ...... started biosimilar infliximab.

@en

P2093

Chan-Bum Choi

http://www.w3.org/2001/XMLSchema#string

Dae-Hyun Yoo

http://www.w3.org/2001/XMLSchema#string

Dam Kim

http://www.w3.org/2001/XMLSchema#string

Eun-Mi Koh

http://www.w3.org/2001/XMLSchema#string

Hye-Soon Lee

http://www.w3.org/2001/XMLSchema#string

Hyoun Ah Kim

http://www.w3.org/2001/XMLSchema#string

Seung-Jae Hong

http://www.w3.org/2001/XMLSchema#string

So-Young Bang

http://www.w3.org/2001/XMLSchema#string

Soo-Kyung Cho

http://www.w3.org/2001/XMLSchema#string

Soyoung Won

http://www.w3.org/2001/XMLSchema#string

P2860

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries.

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists.

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Do rheumatoid arthritis patients have equal access to treatment with new medicines?: tumour necrosis factor-alpha inhibitors use in four European countries.

P2888

s00296-017-3663-z

P304

1007-1014

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00296-017-3663-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chang-hee Suh

Sang-Cheol Bae

P577

2017-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083848433

http://www.w3.org/2001/XMLSchema#string

P698

28214924

http://www.w3.org/2001/XMLSchema#string

Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.

about

P2860

P2860

Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698